Greenstone Biosciences is on a mission to revolutionize the field of drug discovery. We leverage cutting-edge technologies in artificial intelligence (AI), patient-specific-induced pluripotent stem cells (hiPSCs), clinical genomics and computational tools to create a dynamic drug discovery engine that accelerates the process of finding, testing, and developing new drugs.
Our mission is transforming drug discovery and accelerating the development of effective therapies for patients.
Greenstone is a platform computational biology startup company at Stanford Research Park, located at Alexandria Center for Life Sciences. Our mission is transforming drug discovery and accelerating the development of effective therapies for patients.
Greenstone Biosciences, Inc. was established in 2021. We are actively doing bench top science at Alexandria Stanford Research Park, Palo Alto. Co-founder Joseph C. Wu, MD, PhD is the Simon Stertzer Professor of Medicine and Radiology and the Director of Cardiovascular Institute at Stanford University School of Medicine. Founding team members are world class, Stanford, Harvard, and UCLA trained scientists. We are looking to hire top notch scientists who welcome the challenge of getting effective therapies to patients.
Our vision is to transform drug discovery from a slow, sequential, and high-failure process into a rapid, integrated, and novel computational platform accelerating drug discovery. We are integrating high performance drug discovery, AI/Machine Learning computing, human induced pluripotent cells (hiPSCs) technology to achieve success.
Do you want to be a part of an innovative company that helps patients? If you share our vision contact us.
Follow Us: 
